TrialEuropean journal of nuclear medicine and molecular imaging2022

Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation-results from a prospective pilot trial.

Alexander Rühle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.